MAPS Americas 2026 is underway in Denver — and the conversations happening this week are ones we’re paying close attention to.
1,500+ medical affairs professionals from biopharma and MedTech are gathered at the Hyatt Regency for sessions on the topics that matter most. Here are the ones that speak directly to the work we do every day:
🤖 Making AI work in evidence generation — beyond the hype
How medical affairs teams are implementing AI to enhance analytics workflows and move from pilot to real, measurable impact in scientific decision-making
📊 From data to strategic decisions: Building confidence in AI-powered medical insights
Practical experiences from teams embedding AI into medical affairs workflows — and what it actually takes to build trust in AI-generated insights
🔬 Advancing implementation science: Bridging the evidence-to-practice gap
How medical affairs can close the gap between available evidence and real-world clinical practice to improve patient outcomes
📈 Proving medical affairs value to the C-suite
Identifying the impact indicators and new data sources that help medical affairs teams demonstrate strategic value at the highest levels
At Clinakos, our Clarion™ AI Research Agent is built exactly for these challenges. It navigates real, consented patient journeys across 1,500+ oncology and rare disease panels — giving medical affairs teams the AI-powered, evidence-driven intelligence they need to close the gap between data and decisions.
If you’re at MAPS and want to continue the conversation, let’s connect.
